in this issue
Markets :: Fine Chemicals/Biotech :: Industrial Biotech
Metabolix reports net loss, supply situation remains uncertain
8:50 AM MDT | May 10, 2013 | Rebecca Coons
Biopolymer and biobased chemicals firm Metabolix reported a first-quarter net loss of $6.8 million (20 cts/share), compared to net income of $28.8 million (84 cts/share) in the year-ago quarter. The company has been without a production asset since ADM dissolved their polyhydroxyalkanoate (PHA)-based biopolymers joint venture in January of 2012 and stopped production on the jv's behalf. First-quarter 2013 net sales fell 95%, to $1.9 million. The 2012 quarter included $38.9 million of previously deferred revenue related to the jv. First-quarter revenue...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee